Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis

@article{Guckenberger2014SafetyAE,
  title={Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis},
  author={M. Guckenberger and F. Mantel and P. Gerszten and J. Flickinger and A. Sahgal and D. Letourneau and I. Grills and M. Jawad and D. Fahim and J. Shin and B. Winey and J. Sheehan and R. Kersh},
  journal={Radiation Oncology (London, England)},
  year={2014},
  volume={9}
}
  • M. Guckenberger, F. Mantel, +10 authors R. Kersh
  • Published 2014
  • Medicine
  • Radiation Oncology (London, England)
  • PurposeTo evaluate patient selection criteria, methodology, safety and clinical outcomes of stereotactic body radiotherapy (SBRT) for treatment of vertebral metastases.Materials and methodsEight centers from the United States (n = 5), Canada (n = 2) and Germany (n = 1) participated in the retrospective study and analyzed 301 patients with 387 vertebral metastases. No patient had been exposed to prior radiation at the treatment site. All patients were treated with linac-based SBRT using cone… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 48 REFERENCES
    Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases.
    • 150
    • Open Access
    Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial.
    • 215
    • Open Access
    Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
    • 75
    High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions.
    • 418
    • Open Access